Xavo, a leading provider of Software-as-a-Service for Biopharma R&D with offices in Boston, MA, Bayreuth, Germany and Basel, Switzerland, announced today that it will participate in the 2022 SLAS Boston event from February 7th – 9th, 2022. In the exhibition space of the conference, Xavo can be found at Booth #430 where its transformative approach to Sample Management Software will be presented.
As part of Xavo’s mission to accelerate the Biopharma R&D value chain, Xavo is continuously enabling Sample Management in Biopharma R&D by addressing the strategic problem of optimally fulfilling demand in the form of material requests based on available finite lab capacity and material inventory. Xavo R3 helps Sample Management groups to consistently deliver the right material in the right format to the right recipient in the right quality to promise on time every time by providing the best combination of functional and non-functional means.
“As a Corporate Member of SLAS, we are excited to participate in the 2022 SLAS Boston Conference and Exhibition. Because of the pandemic, this is the first time after two years that Xavo is present again at a SLAS event”, says Ralf Sonnefeld, Executive Vice President Marketing & Sales of Xavo. He continues: “We have used this time to rethink our approach to the Biopharma R&D market and how we can best support scientific services that provide material and assay results to scientists. And we can’t wait to show to the SLAS community what we’ve come up with.”
At this year’s SLAS event, Xavo is using the theme of ‘Sample Management Software – reimagined’ to emphasize that it has developed new ways to address latest trends and challenges in the Sample Management realm. Xavo has reimagined how Sample Management Software should be to help scientific services to get their important job done optimally by providing the best combination of functional and non-functional means through its Software-as-a-Service, ‘Xavo R3’